Epstein-Barr virus and Burkitt lymphoma

Area of Science:

• Oncology
• Virology
• Genetics

Background:

• Epstein-Barr virus (EBV), a human herpesvirus, was discovered in Burkitt lymphoma (BL) cells in 1964.
• BL is characterized by chromosomal translocations leading to c-MYC oncogene activation.
• The discovery of EBV spurred research into viral causes of human cancers.

Purpose of the Study:

• To review the current understanding of EBV's role in BL pathogenesis.
• To examine the involvement of the c-MYC oncogene in BL development.
• To discuss implications for novel therapeutic strategies against BL.

Main Methods:

• Literature review of EBV and c-MYC in Burkitt lymphoma.
• Analysis of oncogenic mechanisms in viral-associated cancers.
• Synthesis of current research on BL pathogenesis.

Main Results:

• EBV is a potent growth-transforming agent for B cells.
• BL pathogenesis involves complex interactions between EBV and cellular oncogenes like c-MYC.
• Characteristic chromosomal translocations in BL result in constitutive c-MYC activation.

Conclusions:

• The pathogenesis of BL is intricate, involving both EBV and c-MYC.
• Understanding these factors is crucial for developing targeted therapies.
• New therapeutic strategies may emerge from dissecting the viral and cellular contributions to BL.